Elliott Sun
Private Equity Analist bij Zhouling Private Equity Fund Management (Shanghai) Co., Ltd.
Profiel
Elliott Sun is currently working as an Associate at Zhouling Private Equity Fund Management (Shanghai) Co., Ltd.
Prior to this, he worked as an Investment & Strategic Innovation Associate at Baidu Ventures and Biomap (Beijing) Intelligent Technology Co., Ltd.
Mr. Sun holds a doctorate degree from the University of Oxford, a graduate degree from University College London, and an undergraduate degree from Xiamen University.
Actieve functies van Elliott Sun
| Bedrijven | Functie | Begin |
|---|---|---|
Zhouling Private Equity Fund Management (Shanghai) Co., Ltd.
 Zhouling Private Equity Fund Management (Shanghai) Co., Ltd. Investment ManagersFinance Zhouling Private Equity Fund Management (Shanghai) Co Ltd (LYFE Capital) is a private equity/venture capital firm founded in 2015 by James Zhao. The firm is headquartered in Shanghai, China. | Private Equity Analist | - |
Eerdere bekende functies van Elliott Sun
| Bedrijven | Functie | Einde |
|---|---|---|
Biomap (Beijing) Intelligent Technology Co., Ltd.
 Biomap (Beijing) Intelligent Technology Co., Ltd. Information Technology ServicesTechnology Services Biomap (Beijing) Intelligent Technology Co., Ltd. is a Chinese biotech company founded in 2020 by Robin Li and Wei Liu. The company is based in Beijing, China and is the first biocomputing-driven biotech company in China. Biomaps' technology, Xtrimo, is a protein-centric large language model platform that allows scientists to model life more accurately, from proteins to a system level, and extract novel insights and predictions from limited data. The company's mission is to leverage AI and data to radically improve patients' lives by accelerating the R&D process of early screening/diagnosis, drug discovery, and other precision medicine products. Biomaps' focus is on building their internal AI engine and data collection capabilities to curate their proprietary insights for difficult diseases. The company is a startup biotech company aiming to accelerate novel drug discovery for unmet medical needs. Wei Liu has been the CEO since 2020. | Private Equity Analist | - |
Baidu Ventures
 Baidu Ventures Investment ManagersFinance Baidu Ventures is a venture capital firm headquartered in Beijing, China. The firm was established in 2016. | Private Equity Analist | - |
Opleiding van Elliott Sun
| University of Oxford | Doctorate Degree |
| University College London | Graduate Degree |
| Xiamen University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Zhouling Private Equity Fund Management (Shanghai) Co., Ltd.
Zhouling Private Equity Fund Management (Shanghai) Co., Ltd. Investment ManagersFinance Zhouling Private Equity Fund Management (Shanghai) Co Ltd (LYFE Capital) is a private equity/venture capital firm founded in 2015 by James Zhao. The firm is headquartered in Shanghai, China. | Finance |
Baidu Ventures
Baidu Ventures Investment ManagersFinance Baidu Ventures is a venture capital firm headquartered in Beijing, China. The firm was established in 2016. | Finance |
Biomap (Beijing) Intelligent Technology Co., Ltd.
Biomap (Beijing) Intelligent Technology Co., Ltd. Information Technology ServicesTechnology Services Biomap (Beijing) Intelligent Technology Co., Ltd. is a Chinese biotech company founded in 2020 by Robin Li and Wei Liu. The company is based in Beijing, China and is the first biocomputing-driven biotech company in China. Biomaps' technology, Xtrimo, is a protein-centric large language model platform that allows scientists to model life more accurately, from proteins to a system level, and extract novel insights and predictions from limited data. The company's mission is to leverage AI and data to radically improve patients' lives by accelerating the R&D process of early screening/diagnosis, drug discovery, and other precision medicine products. Biomaps' focus is on building their internal AI engine and data collection capabilities to curate their proprietary insights for difficult diseases. The company is a startup biotech company aiming to accelerate novel drug discovery for unmet medical needs. Wei Liu has been the CEO since 2020. | Technology Services |
